Jung Hyun Yoon Selected Research

Jung Hyun Yoon Research Topics

Disease

18	Neoplasms (Cancer) 07/2022 - 10/2011
12	Breast Neoplasms (Breast Cancer) 07/2022 - 01/2013
5	Lymphatic Metastasis 01/2020 - 01/2013
4	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2020 - 10/2009
3	Thyroid Nodule (Nodule, Thyroid) 01/2019 - 01/2012
3	Prostatic Neoplasms (Prostate Cancer) 09/2015 - 06/2013
2	Papillary Thyroid Cancer 01/2020 - 06/2014
2	Necrosis 01/2019 - 12/2018
2	Ductal Carcinoma 12/2018 - 10/2009
2	Neoplasm Metastasis (Metastasis) 07/2018 - 05/2015
2	Triple Negative Breast Neoplasms 03/2018 - 01/2016
1	Pathologic Complete Response 07/2022
1	Inflammation (Inflammations) 02/2021
1	Margins of Excision 01/2020
1	Breast Carcinoma In Situ 01/2020
1	Lobular Carcinoma 01/2020
1	Contracture 06/2019
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 03/2017
1	Thyroid Neoplasms (Thyroid Cancer) 03/2016
1	Carcinoma (Carcinomatosis) 01/2016
1	Bacterial Infections (Bacterial Infection) 12/2014
1	Myoma 06/2013
1	Leiomyoma (Uterine Fibroids) 06/2013
1	Melanoma (Melanoma, Malignant) 07/2012
1	Ovarian Neoplasms (Ovarian Cancer) 10/2011
1	Lymphadenopathy 10/2011

Drug/Important Bio-Agent (IBA)

4	Hormones (Hormone)IBA 07/2022 - 10/2009
4	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 10/2009
3	Estrogen ReceptorsIBA 01/2020 - 06/2018
3	Antineoplastic Agents (Antineoplastics)IBA 09/2015 - 06/2013
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 12/2018
2	Phenobarbital (Luminal)FDA Link 06/2018 - 01/2016
2	Histone Deacetylase InhibitorsIBA 09/2015 - 06/2013
2	N1- hydroxy- N8- (4- (phenylamino)phenyl)octanediamideIBA 09/2015 - 06/2013
2	Histone Deacetylases (Histone Deacetylase)IBA 09/2015 - 06/2013
2	antigen CYFRA21.1IBA 05/2015 - 01/2013
2	Tumor Biomarkers (Tumor Markers)IBA 01/2013 - 10/2011
1	GadoliniumIBA 04/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2021
1	4-hydroxybenzylcyanideIBA 01/2021
1	GoldIBA 01/2020
1	Ethanol (Ethyl Alcohol)IBA 01/2019
1	Charcoal (Charbon)IBA 07/2018
1	human ERBB2 proteinIBA 06/2018
1	Biomarkers (Surrogate Marker)IBA 03/2018
1	ThioredoxinsIBA 03/2018
1	AutoantibodiesIBA 03/2018
1	Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric 03/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 03/2016
1	Epidermal Growth Factor (EGF)IBA 01/2016
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2016
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 07/2015
1	Keratins (Keratin)IBA 05/2015
1	viriditoxinIBA 12/2014
1	Proteins (Proteins, Gene)FDA Link 12/2014
1	TubulinIBA 12/2014
1	Thyroglobulin FDA Link 06/2014
1	Histones (Histone)IBA 06/2013
1	Vorinostat FDA Link 06/2013
1	Androgen Receptors (Androgen Receptor)IBA 06/2013
1	Melanocyte-Stimulating Hormones (MSH)IBA 07/2012
1	Monophenol Monooxygenase (Tyrosinase)IBA 07/2012
1	Melanins (Melanin)IBA 07/2012
1	ORALIT (ORS)IBA 03/2012
1	OligonucleotidesIBA 01/2012
1	Mucin-1 (CA 15-3 Antigen)IBA 10/2011
1	Carcinoembryonic AntigenIBA 10/2011
1	Keratin-19 (Keratin 19)IBA 10/2011
1	SolutionsIBA 10/2011
1	Saline SolutionIBA 10/2011
1	AntigensIBA 10/2011
1	Estrogens (Estrogen)FDA Link 10/2009

Therapy/Procedure

5	Neoadjuvant Therapy 07/2022 - 01/2016
3	Therapeutics 12/2021 - 12/2018
3	Segmental Mastectomy (Lumpectomy) 01/2021 - 01/2020
3	Thyroidectomy 01/2020 - 02/2015
2	Drug Therapy (Chemotherapy) 09/2015 - 06/2013
1	Radiotherapy 01/2021
1	Sutures (Suture) 06/2019
1	Tattooing 07/2018
1	Simple Mastectomy 07/2016
1	Adjuvant Chemotherapy 07/2016
1	Aftercare (After-Treatment) 03/2015
1	Uterine Artery Embolization 06/2013